Last mentioned: Mar 7, 2026
Final Departure
Official announcement of Marks leaving the agency for the second time.
Initial Friction
Reports surface of Marks considering resignation amid administrative policy shifts.
Operation Warp Speed
Plays a central role in the emergency use authorizations for COVID-19 vaccines.
Appointed Director
Promoted to Director of CBER, overseeing the 'Gold Standard' of vaccine review.
Joins FDA
Dr. Peter Marks joins the FDA as Deputy Director of CBER.
Dr. Peter Marks, the long-serving head of the FDA’s vaccine division, is stepping down for the second time as the Trump administration intensifies its 'Make America Healthy Again' initiatives. His exit marks a critical turning point for the Center for Biologics Evaluation and Research and signals a potential shift in the agency's rigorous approval standards.
This page surfaces every story mentioning Peter Marks across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Peter Marks was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |